Please use this identifier to cite or link to this item: https://doi.org/10.3389/fmicb.2015.01420
DC FieldValue
dc.titlePotential use of phenolic acids as anti-Candida agents: A review
dc.contributor.authorTeodoro, G.R
dc.contributor.authorEllepola, K
dc.contributor.authorSeneviratne, C.J
dc.contributor.authorKoga-Ito, C.Y
dc.date.accessioned2020-09-03T10:35:14Z
dc.date.available2020-09-03T10:35:14Z
dc.date.issued2015
dc.identifier.citationTeodoro, G.R, Ellepola, K, Seneviratne, C.J, Koga-Ito, C.Y (2015). Potential use of phenolic acids as anti-Candida agents: A review. Frontiers in Microbiology 6 (DEC) : 1420. ScholarBank@NUS Repository. https://doi.org/10.3389/fmicb.2015.01420
dc.identifier.issn1664302X
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/174129
dc.description.abstractThere has been a sharp rise in the occurrence of Candida infections and associated mortality over the last few years, due to the growing body of immunocompromised population. Limited number of currently available antifungal agents, undesirable side effects and toxicity, as well as emergence of resistant strains pose a considerable clinical challenge for the treatment of candidiasis. Therefore, molecules that derived from natural sources exhibiting considerable antifungal properties are a promising source for the development of novel anti-candidal therapy. Phenolic compounds isolated from natural sources possess antifungal properties of interest. Particularly, phenolic acids have shown promising in vitro and in vivo activity against Candida species. However, studies on their mechanism of action alone or in synergism with known antifungals are still scarce. This review attempts to discuss the potential use, proposed mechanisms of action and limitations of the phenolic acids in anti-candidal therapy. © 2015 Teodoro, Ellepola, Seneviratne and Koga-Ito.
dc.sourceUnpaywall 20200831
dc.subjectantifungal agent
dc.subjectcarvacrol
dc.subjectcinnamic acid
dc.subjectcoumarin
dc.subjectflavonoid
dc.subjectlignan
dc.subjectlignin
dc.subjectphenol derivative
dc.subjectproanthocyanidin
dc.subjectreactive oxygen metabolite
dc.subjectstilbene derivative
dc.subjectthymol
dc.subjectantifungal activity
dc.subjectCandida albicans
dc.subjectcandidiasis
dc.subjectdrug mechanism
dc.subjectdrug potentiation
dc.subjectdrug safety
dc.subjectenzyme activity
dc.subjectgene expression
dc.subjecthydrophobicity
dc.subjectimmunoregulation
dc.subjectminimum inhibitory concentration
dc.subjectnonhuman
dc.subjectReview
dc.typeReview
dc.contributor.departmentDENTISTRY
dc.description.doi10.3389/fmicb.2015.01420
dc.description.sourcetitleFrontiers in Microbiology
dc.description.volume6
dc.description.issueDEC
dc.description.page1420
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fmicb_2015_01420.pdf1.2 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.